NCT01965301View on ClinicalTrials.gov

First-time-in-man, to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP1.5375

PHASE1TerminatedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy Male Volunteers
Interventions
DRUG

BP1.5375 suspension

single oral dose

DRUG

Diphenhydramine

single oral dose of Diphenhydramine 50mg

DRUG

Placebo

Single oral dose

Trial Locations (1)

2333

Centre for Human Drug Research, Leiden

Sponsors

Lead Sponsor

Bioprojet
All Listed Sponsors
lead

Bioprojet

OTHER